ARCHIVES

Concurrent Trastuzumab and Anthracyclines Not Necessary for High Pathological Response

This article is from The Cancer Letter archive.

Vol. 36 No. 11 | November 29, 2013

Download PDF Visit The Full Archive

Related Articles

Cooperative Groups With Cancer Control Contracts Receive Two Year Renewals

March 25, 1983

SAIC Awarded $5 Billion Contract For NCI-Frederick.

October 3, 2008

NIEHS Awards $5M Grant for New Health Sciences Center to Robert Wood Johnson Medical School

January 20, 1989

Flavopiridol Plus Cisplatin Tested In Phase II Trial

October 26, 2007

Cranial Radiation Eliminated With Personalized Chemo

August 28, 2009

Herberman Outlines NSABP restructuring In Plan To NCI

May 6, 1994